TABLE 2

Summary of PET Quantitative Measures

	PET/CT 1		PET/CT 2		Pairwise difference (D)		Log difference (d)
Parameter	Average	SD	Average	SD	Average	SD	Average	SD
Liver
SUV_mean-A	2.24	0.46	2.16	0.43	−0.08	0.25	−0.035	0.12
SUV_mean-M	2.09	0.32	2.04	0.37	−0.05	0.31	−0.030	0.15
SUV_mean-P	2.15	0.39	2.09	0.40	−0.06	0.29	−0.032	0.13
Tumor
SUV_max-A	14.93	10.05	14.46	10.15	−0.47	2.03	−0.038	0.16
SUV_max-M	9.06	4.04	9.39	3.28	−0.26	1.69	−0.010	0.18
SUV_max-P	11.62	7.81	11.72	7.67	−0.36	1.84	−0.023	0.17
SUV_peak-A	11.57	7.89	11.02	7.44	−0.56	1.66	−0.047	0.17
SUV_peak-M	6.89	3.02	7.32	2.66	0.00	1.44	0.021	0.22
SUV_peak-P	8.93	6.10	9.02	5.68	−0.26	1.56	−0.010	0.20
aSUVmax-A	13.00	9.09	12.52	8.95	−0.48	1.86	−0.048	0.16
aSUVmax-M	7.30	2.93	7.64	2.45	−0.07	1.32	0.010	0.17
aSUVmax-P	9.78	6.95	9.88	6.74	−0.26	1.59	−0.017	0.16
aSUVpeak-A	9.86	7.53	9.37	7.12	−0.49	1.32	−0.044	0.15
aSUVpeak-M	5.34	2.09	5.65	1.83	0.03	1.03	0.026	0.19
aSUVpeak-P	7.31	5.64	7.36	5.31	−0.21	1.19	−0.006	0.17

Results of ACRIN trial are denoted with -A, those from Merck trial with -M, and those from pooled ACRIN and Merck data with -P.